221 related articles for article (PubMed ID: 23236829)
1. [The anti-portal hypertension effect of oleanolic acid in CCl4-induced cirrhosis rats].
Liu CH; Huang XT; Li YY; Zheng X; Li N; Mi SQ; Wang NS
Zhong Yao Cai; 2012 Jun; 35(6):930-5. PubMed ID: 23236829
[TBL] [Abstract][Full Text] [Related]
2. Deleterious effects of silymarin on the expression of genes controlling endothelial nitric oxide synthase activity in carbon tetrachloride-treated rat livers.
Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Jin W; Kwon YH; Shin MK; Yoo TM; Kang JH; Park CS
Life Sci; 2009 Aug; 85(7-8):281-90. PubMed ID: 19527736
[TBL] [Abstract][Full Text] [Related]
3. Polyprenols from Taxus chinensis var. mairei prevent the development of CCl₄-induced liver fibrosis in rats.
Yu J; Wang Y; Qian H; Zhao Y; Liu B; Fu C
J Ethnopharmacol; 2012 Jun; 142(1):151-60. PubMed ID: 22543175
[TBL] [Abstract][Full Text] [Related]
4. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
5. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
6. [Akt gene therapy for cirrhotic rats with portal hypertension].
Huang FZ; Deng G; Liu XY; Luo CQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
[TBL] [Abstract][Full Text] [Related]
7. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis.
Zhang CG; Zhang B; Deng WS; Duan M; Chen W; Wu ZY
World J Gastroenterol; 2016 May; 22(18):4484-500. PubMed ID: 27182159
[TBL] [Abstract][Full Text] [Related]
8. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
[TBL] [Abstract][Full Text] [Related]
10. [The roles of caveolin-1 and endothelial nitric oxide synthase in the development of portal hypertension in rats with liver cirrhosis].
Xu B; Zhu GH; Weng JF; Cai WS; Xia JT; Li SH
Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):184-7. PubMed ID: 18364076
[TBL] [Abstract][Full Text] [Related]
11. Ginkgo biloba extract alleviates liver fibrosis induced by CCl in rats.
Ding J; Yu J; Wang C; Hu W; Li D; Luo Y; Luo H; Yu H
Liver Int; 2005 Dec; 25(6):1224-32. PubMed ID: 16343076
[TBL] [Abstract][Full Text] [Related]
12. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
13. Effects of hepatotrophic factors on the liver after portacaval shunt in rats with portal hypertension.
Zhang ZT; Jiang P; Wang Y; Li JS; Xue JG; Zhou YZ; Yuan Z
Chin Med J (Engl); 2006 Oct; 119(20):1727-33. PubMed ID: 17097021
[TBL] [Abstract][Full Text] [Related]
14. [The effect of Ginkgo biloba extract on portal hypertension and hepatic microcirculation in rats].
Zhang CQ; Zhu YH; Wang J; Liang B; Xu HW; Qin CY
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):245-8. PubMed ID: 17456308
[TBL] [Abstract][Full Text] [Related]
15. [Dynamic change of lipid peroxidation-related protein expression and the intervention effects of Yiguanjian decoction in a rat model of CCl4-induced liver fibrosis].
Tao Q; Wang XN; Mu YP; Feng Q; Peng JH; Liu P; Fu WW; Zhang WM; Hu YY
Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):116-21. PubMed ID: 22464783
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of
Zhang C; Tian X; Zhang K; Li GY; Wang HY; Wang JH
World J Gastroenterol; 2017 Aug; 23(31):5722-5731. PubMed ID: 28883697
[TBL] [Abstract][Full Text] [Related]
18. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
Wang H; Chen XP; Qiu FZ
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and protective effect of an oleanolic acid-enriched extract of A. deliciosa root on carbon tetrachloride induced rat liver injury.
Bai X; Qiu A; Guan J; Shi Z
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():169-73. PubMed ID: 17392098
[TBL] [Abstract][Full Text] [Related]
20. Aqueous extract of Anoectochilus formosanus attenuate hepatic fibrosis induced by carbon tetrachloride in rats.
Shih CC; Wu YW; Lin WC
Phytomedicine; 2005 Jun; 12(6-7):453-60. PubMed ID: 16008122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
